Roivant Sciences Ltd. (NASDAQ:ROIV)’s traded shares stood at 2.04 million during the last session. At the close of trading, the stock’s price was $8.50, to imply a decrease of -1.05% or -$0.09 in intraday trading. The ROIV share’s 52-week high remains $10.00, putting it -17.65% down since that peak but still an impressive 70.35% since price per share fell to its 52-week low of $2.52. The company has a valuation of $6.28B, with an average of 2.03 million shares in intraday trading volume over the past 10 days and average of 2.49 million shares over the past 3 months.
Analysts have given a consensus recommendation of a Buy for Roivant Sciences Ltd. (ROIV), translating to a mean rating of 1.70. Of 9 analyst(s) looking at the stock, 0 analyst(s) give ROIV a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 9 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -$0.39.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
Roivant Sciences Ltd. (NASDAQ:ROIV) trade information
After registering a -1.05% downside in the last session, Roivant Sciences Ltd. (ROIV) has traded red over the past five days. The stock hit a weekly high of 8.94 this Thursday, 03/16/23, dropping -1.05% in its intraday price action. The 5-day price performance for the stock is 10.53%, and -2.75% over 30 days. With these gigs, the year-to-date price performance is 6.38%. Short interest in Roivant Sciences Ltd. (NASDAQ:ROIV) saw shorts transact 12.83 million shares and set a 4.85 days time to cover.
Analysts on Wall Street suggest a consensus price target of $13.63, implying an increase of 37.64% to the stock’s current value. The extremes give us $10.00 and $19.00 for target low and target high price respectively. As such, ROIV has been trading -123.53% off suggested target high and -17.65% from its likely low.
Roivant Sciences Ltd. (ROIV) estimates and forecasts
Looking at statistics comparing Roivant Sciences Ltd. share performance against respective industry, we note that the company has underperformed competitors. Roivant Sciences Ltd. (ROIV) shares are 130.98% up over the last 6 months, with its year-to-date growth rate lower than industry average at -41.27% against 9.40%. Revenue is forecast to grow 4.90% this quarter before jumping 7.70% for the next one. The rating firms project that company’s revenue will grow 4.80% compared to the previous financial year.
Revenue forecast for the current quarter as set by 7 analysts is $14.64 million. Meanwhile, for the quarter ending Mar 2023, a total of 7 analyst(s) estimate revenue growth to $19.05 million.Earnings reports from the last fiscal year show that sales brought in $24.34 million and $9.22 million respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to fall -39.90% before jumping 106.50% in the following quarter.
ROIV Dividends
Roivant Sciences Ltd. has its next earnings report out on February 13. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Roivant Sciences Ltd. has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
Roivant Sciences Ltd. (NASDAQ:ROIV)’s Major holders
Roivant Sciences Ltd. insiders hold 50.41% of total outstanding shares, with institutional holders owning 50.74% of the shares at 102.32% float percentage. In total, 50.74% institutions holds shares in the company, led by QVT Financial LP. As of Sep 29, 2022, the company held over 129.39 million shares (or 18.37% of shares), all amounting to roughly $416.65 million.
The next major institution holding the largest number of shares is SB Investment Advisers (UK) LTD with 99.38 million shares, or about 14.11% of shares outstanding. As of the market price on Sep 29, 2022, these shares were worth $319.99 million.
We also have Fidelity Growth Company Fund and Fidelity Select Portfolios – Biotechnology as the top two Mutual Funds with the largest holdings of the Roivant Sciences Ltd. (ROIV) shares. Going by data provided on Nov 29, 2022, Fidelity Growth Company Fund holds roughly 7.03 million shares. This is just over 1.00% of the total shares, with a market valuation of $37.69 million. Data from the same date shows that the other fund manager holds a little less at 5.96 million, or 0.85% of the shares, all valued at about 31.93 million.
